SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-02
👔
Tango Therapeutics, Inc.
@TNGX_InsiderForm 4 Filing: Crystal Adam Sells $939,308.184 of $TNGX
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Tango Therapeutics, Inc.
Ticker: $TNGX
Transaction Value
$939,308.184
Price/Share: $17.39
transaction date
2026-07-01
Shares: 54,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Crystal Adam, holds the title of President, R&D at Tango Therapeutics, Inc..
On 2026-07-01, the insider transacted 54,000 shares.The shares were transacted at a weighted average price of $17.39 per share, resulting in a total market-relevant value of $939,308.184.
Executive Summary Summary
Crystal Adam (President, R&D) sold $939K of $TNGX
Post-Transaction Position: 123,114 shares
SEC Accession No: 0001193125-26-295124 (CIK: 1825445)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.